Quality assurance managers and software QA directors

Quality assurance managers join product and engineering teams to establish test ownership and make release criteria explicit. Bring one in when escaped defects recur or testing effort no longer matches business risk.

• Risk-based test planning: Map critical workflows to coverage and prioritize validation by failure impact.
• Defect management: Establish severity definitions and triage decisions in Jira or Azure DevOps. Track unresolved defects against acceptance criteria rather than treating ticket counts as a quality measure.

Test delivery leads coordinate validation across application teams and external suppliers. They maintain integrated test schedules and resolve dependencies that prevent testing from starting, such as missing environments or unusable test data.

For system integration testing and user acceptance testing, the lead agrees scope with business owners and coordinates execution. They track defect retests and prepare release-readiness evidence, including coverage gaps and accepted risks. Your release owner keeps the go-live decision; the lead makes its technical basis visible.

Technical QA leads assess whether automated checks provide dependable release feedback. They review flaky tests and suite duration, then work with developers to place checks at the appropriate test layer.

• Automation direction: Review Playwright or Cypress coverage for critical workflows and identify gaps better addressed through API tests.
• Pipeline controls: Configure quality gates in GitHub Actions or Azure DevOps. Define failure thresholds and exception ownership so unreliable tests do not become permanent release blockers.

Software QA directors take responsibility for quality priorities across products when leadership capacity is limited or delivery performance has deteriorated. They assess current responsibilities and agree corrective actions with engineering and business owners.

Interim leadership can include managing QA leads and reviewing supplier test commitments. For troubled releases, the director examines defect trends and missing validation evidence, then establishes a recovery backlog with named owners. Ongoing reporting distinguishes test completion from residual release risk, so stakeholders can judge readiness against explicit criteria.